MEN1, caused by mutations in the MEN1 gene, classically leads to parathyroid, pituitary, and pancreatic neuroendocrine tumors, but adrenal tumors—predominantly non-functioning—occur in up to 40% of patients [15,16,17,18]. Here, MEN1 is linked to adrenal gland neoplasm.